These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3264826)

  • 1. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
    Gottschalk A; Hoffer PB
    Invest Radiol; 1988 Nov; 23(11):879-80. PubMed ID: 3264826
    [No Abstract]   [Full Text] [Related]  

  • 2. Computed tomography in aging and senile dementia of the Alzheimer type.
    de Leon MJ; George AE
    Adv Neurol; 1983; 38():103-22. PubMed ID: 6604399
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia.
    Chawluk JB; Dann R; Alavi A; Hurtig HI; Gur RE; Resnick S; Zimmerman RA; Reivich M
    Int J Rad Appl Instrum B; 1990; 17(8):797-804. PubMed ID: 2079426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of positron emission tomography data for cerebral atrophy.
    Herscovitch P; Auchus AP; Gado M; Chi D; Raichle ME
    J Cereb Blood Flow Metab; 1986 Feb; 6(1):120-4. PubMed ID: 3484745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cranial computerised tomography in dementia of the Alzheimer type.
    Burns A
    Br J Psychiatry Suppl; 1990; (9):10-5. PubMed ID: 2291817
    [No Abstract]   [Full Text] [Related]  

  • 7. [Homonymous hemianopia and posterior cortical atrophy].
    Formaglio M; Krolak-Salmon P; Tilikete C; Bernard M; Croisile B; Vighetto A
    Rev Neurol (Paris); 2009 Mar; 165(3):256-62. PubMed ID: 19124140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior cortical atrophy variants of Alzheimer's disease.
    Aharon-Peretz J; Israel O; Goldsher D; Peretz A
    Dement Geriatr Cogn Disord; 1999; 10(6):483-7. PubMed ID: 10559564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior cortical atrophy variant of Alzheimer's dementia-A case report.
    Mukku SSR; Chintala H; Nagaraj C; Mangalore S; Sivakumar PT; Varghese M
    Asian J Psychiatr; 2018 Jun; 35():109-112. PubMed ID: 29864740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 FDG and F-18 Tau PET in posterior cortical atrophy.
    Tripathi M; Bansal A; Baghel V; Kumar P; Bal C
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1779-1780. PubMed ID: 28584971
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.
    Kuhl DE; Minoshima S; Fessler JA; Frey KA; Foster NL; Ficaro EP; Wieland DM; Koeppe RA
    Ann Neurol; 1996 Sep; 40(3):399-410. PubMed ID: 8797529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
    Fazekas F; Alavi A; Chawluk JB; Zimmerman RA; Hackney D; Bilaniuk L; Rosen M; Alves WM; Hurtig HI; Jamieson DG
    J Nucl Med; 1989 Oct; 30(10):1607-15. PubMed ID: 2795200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging in Alzheimer's disease.
    Albert MS; Lafleche G
    Psychiatr Clin North Am; 1991 Jun; 14(2):443-59. PubMed ID: 2062727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
    Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
    Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease.
    McDonough IM; Bischof GN; Kennedy KM; Rodrigue KM; Farrell ME; Park DC
    Neurobiol Aging; 2016 Oct; 46():68-75. PubMed ID: 27460151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar atrophy: relationship to aging and cerebral atrophy.
    Koller WC; Glatt SL; Fox JH; Kaszniak AW; Wilson RS; Huckman MS
    Neurology; 1981 Nov; 31(11):1486-8. PubMed ID: 7198196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's dementia.
    Chase TN; Tamminga CA
    Am J Psychiatry; 1995 Aug; 152(8):1110. PubMed ID: 7625456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.